These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11513751)

  • 1. Local and spatial factors determining HIV-1 protease substrate recognition.
    Hazebrouck S; Machtelinckx-Delmas V; Kupiec JJ; Sonigo P
    Biochem J; 2001 Sep; 358(Pt 2):505-10. PubMed ID: 11513751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion of thymidylate synthase into an HIV protease substrate.
    Kupiec JJ; Hazebrouck S; Leste-Lasserre T; Sonigo P
    J Biol Chem; 1996 Aug; 271(31):18465-70. PubMed ID: 8702491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
    Goodenow MM; Bloom G; Rose SL; Pomeroy SM; O'Brien PO; Perez EE; Sleasman JW; Dunn BM
    Virology; 2002 Jan; 292(1):137-49. PubMed ID: 11878916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
    Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM
    Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenesis of protease cleavage sites in the human immunodeficiency virus type 1 gag polyprotein.
    Tritch RJ; Cheng YE; Yin FH; Erickson-Viitanen S
    J Virol; 1991 Feb; 65(2):922-30. PubMed ID: 1987379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate recognition in HIV-1 protease: a computational study.
    Perez MA; Fernandes PA; Ramos MJ
    J Phys Chem B; 2010 Feb; 114(7):2525-32. PubMed ID: 20121080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-evolution of drug resistance and broadened substrate recognition in HIV protease variants isolated from an Escherichia coli genetic selection system.
    Koivisto JM; Poulsen NR; Larsen BS; Weibull MGM; Stein A; Doro F; Winther JR; Lindorff-Larsen K; Willemoës M
    Biochem J; 2022 Feb; 479(4):479-501. PubMed ID: 35089310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-Galactosidase containing a human immunodeficiency virus protease cleavage site is cleaved and inactivated by human immunodeficiency virus protease.
    Baum EZ; Bebernitz GA; Gluzman Y
    Proc Natl Acad Sci U S A; 1990 Dec; 87(24):10023-7. PubMed ID: 2124694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of efficiently cleaved substrates for HIV-1 protease using a phage display library and use in inhibitor development.
    Beck ZQ; Hervio L; Dawson PE; Elder JH; Madison EL
    Virology; 2000 Sep; 274(2):391-401. PubMed ID: 10964781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding kinetics and substrate selectivity in HIV-1 protease-Gag interactions probed at atomic resolution by chemical exchange NMR.
    Deshmukh L; Tugarinov V; Louis JM; Clore GM
    Proc Natl Acad Sci U S A; 2017 Nov; 114(46):E9855-E9862. PubMed ID: 29087351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A side chain at position 48 of the human immunodeficiency virus type-1 protease flap provides an additional specificity determinant.
    Moody MD; Pettit SC; Shao W; Everitt L; Loeb DD; Hutchison CA; Swanstrom R
    Virology; 1995 Mar; 207(2):475-85. PubMed ID: 7886951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of folding preferences of cleavage junctions of HIV-1 precursor proteins for regulation of cleavability.
    Ode H; Yokoyama M; Kanda T; Sato H
    J Mol Model; 2011 Feb; 17(2):391-9. PubMed ID: 20480379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of substrates on the kinetics and the in vivo threshold activity of mutant HIV-1 proteases.
    Ermolieff J; Lin X; Tang J
    Adv Exp Med Biol; 1998; 436():47-51. PubMed ID: 9561198
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo processing of Pr160gag-pol from human immunodeficiency virus type 1 (HIV) in acutely infected, cultured human T-lymphocytes.
    Lindhofer H; von der Helm K; Nitschko H
    Virology; 1995 Dec; 214(2):624-7. PubMed ID: 8553565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered gag polyprotein cleavage specificity of feline immunodeficiency virus/human immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system.
    Lin YC; Brik A; de Parseval A; Tam K; Torbett BE; Wong CH; Elder JH
    J Virol; 2006 Aug; 80(16):7832-43. PubMed ID: 16873240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cleavage of HIV-1 gag polyprotein synthesized in vitro: sequential cleavage by the viral protease.
    Erickson-Viitanen S; Manfredi J; Viitanen P; Tribe DE; Tritch R; Hutchison CA; Loeb DD; Swanstrom R
    AIDS Res Hum Retroviruses; 1989 Dec; 5(6):577-91. PubMed ID: 2692658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate specificity of the human (type 1) and simian immunodeficiency virus proteases.
    Debouck C
    Adv Exp Med Biol; 1991; 306():407-15. PubMed ID: 1812737
    [No Abstract]   [Full Text] [Related]  

  • 18. Polymorphisms in p1-p6/p6* of HIV type 1 can delay protease autoprocessing and increase drug susceptibility.
    Whitehurst N; Chappey C; Petropoulos C; Parkin N; Gamarnik A
    AIDS Res Hum Retroviruses; 2003 Sep; 19(9):779-84. PubMed ID: 14585208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-evolution of nelfinavir-resistant HIV-1 protease and the p1-p6 substrate.
    Kolli M; Lastere S; Schiffer CA
    Virology; 2006 Apr; 347(2):405-9. PubMed ID: 16430939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of human immunodeficiency virus type 1 protease increases intracellular cleavage of Gag and reduces virus infectivity.
    Luukkonen BG; Fenyö EM; Schwartz S
    Virology; 1995 Feb; 206(2):854-65. PubMed ID: 7856098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.